Cargando…

The impact of pharmaceutical innovation on the burden of disease in Canada, 2000–2016

We perform an econometric assessment of the role that pharmaceutical innovation—the introduction and use of new drugs—has played in reducing the burden of disease in Canada, by investigating whether diseases for which more new drugs were launched had larger subsequent reductions in disease burden. S...

Descripción completa

Detalles Bibliográficos
Autor principal: Lichtenberg, Frank R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698939/
https://www.ncbi.nlm.nih.gov/pubmed/31440578
http://dx.doi.org/10.1016/j.ssmph.2019.100457